09774
Fmoc-Bpa-OH
≥98.0%
别名:
Fmoc-L-4-苯甲酰基苯丙氨酸
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C31H25NO5
化学文摘社编号:
分子量:
491.53
UNSPSC Code:
12352209
NACRES:
NA.26
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
7672022
Quality Level
assay
≥98.0%
form
powder
reaction suitability
reaction type: Fmoc solid-phase peptide synthesis
color
white
application(s)
peptide synthesis
functional group
Fmoc
storage temp.
2-8°C
SMILES string
OC(=O)[C@H](Cc1ccc(cc1)C(=O)c2ccccc2)NC(=O)OCC3c4ccccc4-c5ccccc35
InChI
1S/C31H25NO5/c33-29(21-8-2-1-3-9-21)22-16-14-20(15-17-22)18-28(30(34)35)32-31(36)37-19-27-25-12-6-4-10-23(25)24-11-5-7-13-26(24)27/h1-17,27-28H,18-19H2,(H,32,36)(H,34,35)/t28-/m0/s1
InChI key
SYOBJKCXNRQOGA-NDEPHWFRSA-N
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Xue Zhi Zhao et al.
Molecules (Basel, Switzerland), 23(8) (2018-07-28)
HIV-1 integrase (IN) inhibitors represent a new class of highly effective anti-AIDS therapeutics. Current FDA-approved IN strand transfer inhibitors (INSTIs) share a common mechanism of action that involves chelation of catalytic divalent metal ions. However, the emergence of IN mutants
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 235199-500MG | 04061838784964 |
| 8510710001 | 04027269083601 |
| 8510710005 | 04027269083618 |
| 235199-1G | 04061826661826 |
| 09774-1G | 04061826100394 |